CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
06/17/2026
Back to search
Official data from USPTO
GAIPET
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
06/18/2026
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
11/08/2023
Registration date
01/28/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/28/2025
Last transaction
06/18/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
CN
Examiner
MORAN, CAROLINE L
Law office
N70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
ARGORNA PHARMACEUTICALS CO., LTD
Representatives
Jonathan M. Rixen Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical reagentsother than for medical or veterinary purposes; biological preparations for use in industry and scienceother than for medical or veterinary purposes; diagnostic preparations for scientific useother than for medical or veterinary purposes; test paperchemical; chemical preparations for scientific purposesother than for medical or veterinary use; biochemicals preparations for scientific use; chemical substances for analyses in laboratories for scientific useother than for medical or veterinary purposes; reagent paperother than for medical or veterinary purpose; biological preparations for cell cultureother than for medical or veterinary use; diagnostic reagents and preparations for scientific use except for medical and veterinary use; active chemical ingredients for use in the manufacture of pharmaceuticals for treating tumorsasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia
Class 5
Medicines for human purposes for treating tumorsasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; biochemical medicines for the treatment of tumorsasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; pharmaceutical preparations for the treatment of tumorsasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; chemical reagents for medical and veterinary purposes; biological preparations for medical purposes for treating tumorsasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; reagent paper for medical purposes; drugs for medical purposes for treating tumorsasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; diagnostic preparations for medical purposes; vaccines
Class 42
Scientific development and research services in the field of drugs; vaccine research and development services; scientific research and development of new products for others; scientific research; research of biochemistry; biotechnology research; pharmaceutical drug research; development services in the field of pharmaceutical drugs; medical research service; biomedical research services
Publications
History of USPTO decisions and trademark events.
27 publications found
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/12/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/05/2025
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
08/29/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/27/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/27/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/15/2025
FIMP
FINAL DISPOSITION PROCESSED
08/15/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/29/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/28/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/28/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/10/2024
PUBO
PUBLISHED FOR OPPOSITION
12/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/18/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/17/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/17/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/17/2024
RFNT
REFUSAL PROCESSED BY IB
08/11/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/24/2024
RFRR
REFUSAL PROCESSED BY MPU
07/24/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/28/2024
CNRT
NON-FINAL ACTION WRITTEN
06/27/2024
DOCK
ASSIGNED TO EXAMINER
06/17/2024
MAFR
APPLICATION FILING RECEIPT MAILED
04/05/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/01/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/28/2024
Continuous trademark protection
Get notified about every new filing that threatens GAIPET or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.